Combined, these studies collectively do not support the hypothesis that expression of PPARβ/δ is increased by APC/β-CATENIN/TCF4 signaling in colon cancer, as both the mouse and human models examined include those with defective APC signaling. The gene discussed is TCF4; the disease is colonic neoplasm.